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EPIGENETIC BARRIERS TO HUMAN GYNOGENESIS  
 
OLIVIA DUONG NGUYEN 
ABSTRACT 
 
There have been leaps in both fields of epigenetics and reproductive technology. 
This has culminated in the production of bi-maternal mouse offspring through a few 
studies utilizing direct gene mutations as functional-imprints. While these genetic 
interventions result in positive results, it has yet to be described, in full, what mechanisms 
underlie the epigenetic barriers to human gynogenesis. 
Between maternal and paternal imprints, differences in methylation patterns of 
CpG island promoters, non-coding regions, microsatellites, transposons, and histones 
result in differences in higher order chromatin structure, which ultimately impacts 
expression of certain genes. While the necessary components of a minimal paternal 
epigenetic program are described, programming this imprint onto m2, a hypothetical, 
experimentally-produced maternal genome with a paternal epigenome is still not 
elucidated. Sequential timing of imprint acquisition and maintenance and the numerous 
regulatory factors associated with them illuminate how difficult potential assisted 
reproductive epigenetic interventions will be. Other processes like histone-protamine 
exchange which also plays a crucial factor in structural regulation of imprints, as well as 
signaling through and after fertilization, pose logistical problems to creating a 
gynogenote through epigenetic means. Lastly, ethics surrounding the introduction of 
dangerous mutations and epialleles into the human population add another wall of caution 
and hesitance in exploring human gynogenesis as a reproductive technology.  
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INTRODUCTION 
Gynogenesis is known to naturally occur in fish, amphibians, and plant species1. 
Due to the evolutionary adaption of imprinting, gynogenesis in mammals is not naturally 
observed. Nonetheless, mammalian gynogenesis was made successful in an experiment 
by Kono et al. (2004). Kaguya, one of 24 surrogates, was developed from a pool of 371 
gynogenetically-engineered (ngH19 Δ3 /fgwt) mouse embryos. She was reproductively 
competent, creating curiosity about the advancement of human infertility treatment and 
the expansion of available assisted reproductive technologies (ART) for Lesbian or 
assigned-female-at-birth (AFAB) couples. Currently, reproductive technologies for 
AFAB couples rely on the use of donated sperm and limit the autonomy of AFAB 
couples. Developments like intra-cytoplasmic sperm injections (ICSI) that bypass the 
zona pellucida and deliver chromosomes directly into the secondary oocyte and actin 
polymerization inhibitor cytochalasin B that suppress second polar body extrusion during 
egg activation, promote diploidy, and ultimately enable parthenogenesis illustrate the 
potential ART for AFAB couples. However, while there is a desire to grant full autonomy 
to AFAB couples—to give them the fulfillment of having a child with bi-maternal 
contribution—issues of imprinting, normal development and growth, trans-generational 
fertility, population epigenetics, and societal risks must be addressed. 
Specific Aims 
The carefully orchestrated spatiotemporal events of embryogenesis and epigenetic 
regulation allow physiological development of offspring. Tampering with the imprinted 
gene network would be premature and burdened with unknown risks. Thus, hypothetical 
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interventions for AFAB couple infertility treatment are discussed with a review of 
epigenetic barriers to ovum-ovum fertilization, embryogenesis, and normal development 
of the hypothetical human gynogenote. Players and processes that are involved in 
imprinting and in imprint maintenance are described. Discussion elaborates on the 
production of m2, an oocyte with a maternal epigenome that is reprogrammed to 
functionally resemble a paternal epigenome. Ultimately, this literature review seeks to 
pose questions for further probing and lay out some of the considerations that must be 
taken before human gynogenesis can be attempted. 
 
The Consequences of Knocking Out Imprints 
Imprinting causes non-equivalent expression of certain genes in the mammalian 
species through parent-specific effects in the offspring. Imprinted genes are functionally 
mono-allelic, as they are controlled by local differentially methylated regions (DMRs) in 
various body tissues. As the name implies, these DMRs are differentially modified during 
male and female gametogenesis. Imprinted genes code for a wide array of products like 
non-coding RNA, growth factors, and transcription factors that are important for 
development, metabolism, immune function (e.g. defense against cancer), 
neurodevelopment, behavior, and reproduction2. The effect of imprints is often masked 
since fertilization in vivo occurs between sperm and ova and the inheritance of traits 
appear to be bi-allelically inherited3. However, the function of imprints has been 
characterized by manipulation of early mouse embryos and observation of parent-specific 
effects in offspring with imprinting diseases.  
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In these early experiments, diploid mouse embryos were created, producing 
gynogenotes and androgenotes (with pronuclear transplantation), and parthenogenotes 
(see Appendix; see Figure 18). None of these embryos survived to term; specifically, the 
bi-paternal and bi-maternal embryos could develop to the blastocyst stage but died after 
implantation4,5. Androgenotes in these earlier experiments were observed to have 
relatively poor quality embryonic tissue with well-developed extra-embryonic 
membranes and trophoblast. This coincided with physical findings in hydatidiform moles, 
naturally-occurring androgenotes, which also showed overgrowth of extra-embryonic 
structures and underdevelopment of embryonic tissue2. Gynogenotes had relatively 
normal quality embryonic tissue with underdeveloped extra-embryonic tissue5. Ovarian 
teratomas, diploid and derived from a single maternal genome, resemble parthenogenotes 
and show developed embryonic tissue without extra-embryonic structures2. Now it is 
known that this phenotype is supported by altered paternally-expressed-gene-10 (PEG10) 
expression, specifically a double “dose” of methylation from maternal lines at PEG10 
promoter sites, in humans and mice. Peg10 knock-out mice show similar results with 
severe loss of spongiotrophoblast and labyrinth layers 6. 
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Figure 1. Production of experimental embryos2
  
Figure 2. Comparison of embryo proper and extra-embryonic tissues among 
experimental mouse embryos 3
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Broad strokes were made earlier to understand that imprints are crucial for normal 
embryological development and growth. Parental conflict theory was popular, and 
claimed that paternal expression of genes during early development leads to positive 
growth and maternal expression of genes leads inhibition of development. Imprinting and 
tissue development, as it is known now, is not that simple. In humans, maternally-
expressed genes (MEGs) PPP1R9A and ASB4 are found in extra-embryonic tissues 6. In 
mice, Mash2/ Ascl2, also a maternally-expressed transcription factor, contribute to 
placental development. Knockout of Mash2/ Ascl2 results in early embryonic lethality 
caused by loss of spongiotrophoblast and labyrinth layers7—disproving the earlier, black-
and-white parental conflict theory. Regardless of whether MEGs definitively cause 
inhibition of growth or not, the function of imprints from both maternal and paternal 
sources remains critical to the development of mammalian offspring. To achieve human 
gynogenesis, molecular, structural, temporal, and regulatory differences in imprint 
establishment and maintenance between ova and sperm must be overcome.  
CONSIDERATIONS FOR INTERVENTION 	
Paternal vs. Maternal Imprint: Structural Features 	
Paternal imprinting control regions (ICRs) and maternal ICRs are found in 
different locations and in different quantity, instituting different higher order chromatin 
looping and specific expression of certain genes for development and survival. The 
maternal imprint, as a whole, consists mainly of methylated CpG island ICRs located at 
promoter sites (see Table 1) 3,8. Paternally imprinted genes on the other hand have fewer 
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ICRs that localize to intergenic regions and tend to be CpG poor, yet the overall paternal 
imprint has a greater degree of methylation compared to the maternal line. This 
discrepancy in total methylation may be due to the fact that the paternal imprint consists 
largely of repetitive DNA elements, which contain the majority of the CpGs present in 
the mammalian genome. piRNAs and associated PIWI proteins expressed in male tissues 
direct CpG DNA methylation on transposition loci 9, a type of repetitive element that 
must be repressed to prevent reactivation and damage that would result in cellular 
apoptosis of germ cells. 
Only three developmentally-regulated imprinted loci have been reported in the 
mouse paternal germline: H19/Igf2, Gtl2/Dlk1 containing the three imprinted protein-
coding genes Dlk1, Rtl1, and Dio3), and A19/Rasgrf1 10. H19/Igf2 is located on mouse 
chromosome 7, and operates on an “insulator model.” Imprint regulation of the ICR 
located between H19 and Igf2 involves an enhancer-blocking protein, CTCF, a somatic 
regulator of imprinted gene expression that binds onto the un-methylated ICR 11. This 
binding prevents association between Igf2 promoters and enhancers by inducing higher-
order looping, and thus causing downregulation of gene expression (see Figure 4). In the 
maternal line, this ICR is un-methylated; in contrast, the paternal ICR is methylated and 
fails to bind CTCF, allowing Igf2 to be expressed. According to the insulator model, 
reciprocal parent-specific effects manifest with changes in methylation dosages: if both 
parental ICRs are un-methylated, H19 would be bi-allelically expressed and Igf2 
silenced; if both parental ICRs are methylated then H19 would be repressed and Igf2 bi-
allelically expressed. However, as elucidated by Ulaner et al., (2003), CTCF may not be 
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the only regulator involved in expression of H19/Igf2. There could be bi-allelic binding 
of CTCF at the ICR yet Igf2 expression, hinting that there may be multiple enhancers and 
silencers upstream of the gene in different body tissues. 
Figure 3. H19/Igf2 and Peg13/ Kcnk9 Imprinted Gene Regulation 13. 
 
Dlk1 and Gtl2 are also reciprocally imprinted genes in the mouse, located only 80 
kb from each other. In the absence of DMR methylation, Dlk1 becomes repressed and the 
silent allele of Gtl2 becomes activated on the paternal allele. Despite its structural 
similarities to H19/Igf2, the Gtl2/Dlk1 ICR has additional regulatory features. The 
intergenic DMR (IG-DMR) that regulates the Dlk1-Dio3 domain does not contain 
consensus CTCF-binding sites 14, and instead works in conjunction with the Gtl2 
promoter (Gtl2-DMR). 
There seems to be a necessary mode of inheritance between parental cis-elements 
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IG-DMR and Gtl2-DMR: there must be methylation on both the IG-DMR and the Gtl2-
DMR of one parental allele and de-methylation on both the IG-DMR and the Gtl2-DMR 
of the other parental allele. Deletion of either maternal un-methylated IG-DMR or 
deletion of the paternal methylated Gtl2-DMR results in 2-fold over- or under-expression 
of Dlk, associated skeletal defects, and perinatal death, respectively15. Additionally, 
“imprinted gene rescue” employed in the study by Takahashi et al. (2010) attempted to 
compensate for loss of imprinted gene expression. Simply having the correct dosage of 
methylation on IG-DMRs and Gtl2-DMRs was not enough to prolong life for all double 
mutant pups (explained further below). Despite having decent birth rates and normal 
physical development, 4/15 pups survived past three weeks of birth, grew normally as 
adults, and retained reproductive competence.  
Normally, the IG-DMR and the Gtl2-DMR are un-methylated on the maternal 
allele and methylated on the paternal allele. Interestingly, the oocytes and sperm are not 
differentially methylated at the Gtl2-DMR until after fertilization when the paternal allele 
specifically becomes hypermethylated14. Furthermore, knock-out studies found that loss 
of un-methylated IG-DMR from the maternal allele (IG-DMR -/+) resulted in “paternal 
reversion,” methylation of the Gtl2-DMR and expression of Rtl1 and Dio3 paternally-
expressed genes (PEGs) 29. Removal of methylation at Gtl2-DMR in the paternal allele in 
two separate studies seemed to also switch its expression to maternal genes, there being a 
sizeable increase in anti-Rtl1, Rian, and Mirg (non-coding miRNA, snRNA, and 
miRNAs) and decrease in PEGs compared to wild type 15. This is where the more 
complex regulatory mechanisms involved with imprinting come into play with the 
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Dlk1/Dio3 ICR. 
Figure 4. Comparison of Gene Expression Among Altered DMRs in Dlk1-Dio3 
Domain 15. 
 
ncRNA Gtl2 is expressed from the maternal chromosome through paternal 
activation, which is facilitated by methylation (Figure 5, Sanli & Feil, 2015). Gtl2 
recruits Trithorax protein complexes known to facilitate active chromatin states through 
H3K4 methylation and makes expression of maternal genes possible13. An alternative 
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model suggests that the IG-DMR in the maternal allele can in fact function as an activator 
independent of methylated-paternal IG-DMR. 
Lin et al. (2013) showed that deletion of the un-methylated copy of IG-DMR on 
the maternal allele (KO/+) results in the bi-allelic expression of Dlk1 and the bi-allelic 
repression of Gtl2 while the deletion of the methylated copy of IG-DMR on the paternal 
allele (+/KO) results in no change in gene expression compared to wild type (+/+). With 
+/KO, there was normal activation of maternal IG-DMR and normal expression of Gtl2, 
MBII-48, MBII-48, MBII-78 (snoRNA), and maternally-expressed mir-127 and mi-136, 
proposed to be small interfering RNAs that trigger cleavage of the usually-silenced 
paternal Rtl transcripts. 
Figure 5. Gtl2/ Dlk1 ICR Imprinted Gene Regulation 13. 
 
The fact that deletion of the IG-DMR on the paternal allele did not alter Dlk1 
activity or result in loss of imprinting at Gtl2 informs us that there may be some 
flexibility in manipulation of imprinting. However, it should be noted that in Takahashi’s 
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study (2010), (IG-DMR -/+)(Gtl2-DMR +/-) double mutants’ expression of ncRNA did 
not return to wild type levels; and in their previous study, deletion of Gtl2 led to 
hypoplastic alveoli and hepatocellular necrosis ultimately resulting in postnatal death. 
Timing of methylation placement may play a contributory role. Placing methylation on 
Gtl2-DMR in the maternal allele before fertilization may contribute to the growth 
retardation observed during weaning stages in (IG-DMR -/+)(Gtl2-DMR +/-) double 
mutants. It seems that establishing the Gtl2-DMR imprint at the correct time may enable 
the ncRNAs in the Dlk1-Dio3 domain to contribute to the pre-implantation embryo’s 
pluripotent potential 15. 
Another level of imprinting regulation also occurs at the histone level. In fact, 
there are profound, almost signatory, levels of H3K4me3 localized at paternally-
expressed genes and non-coding RNAs in human sperm17. For example, the DLK-DIO3 
imprinting domain (14q32.33) in humans has paternally-expressed genes such 
as DLK1and RTL1, which have moderate levels of H3K4me3 in their promoters. 
Maternally-expressed genes and non-coding RNAs and paternally-methylated regions, in 
contrast, lack H3K4me3 and contain moderate levels of H3K9me317. Aside from keeping 
chromatin open at paternal loci, H3K4me3 has a role in keeping DNA un-methylated in 
the early embryo. 
Rasgrf1, the last paternally-methylated imprinted gene, is imprinted in the 
mouse—not human—and is located on chromosome 9. It utilizes CTCF in its regulation 
of gene expression 18,19, as well as another mechanism involving pit-RNA (piRNA-
targeted noncoding RNA), which is involved in Rasgrf1-DMR de novo methylation. 
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There is a repetitive sequence found adjacent to Rasgrf1-DMR, located 30 kb 5’ before 
the start of transcription, that functions as a promoter for pit-RNA and can be methylated 
and maintained on the paternal allele and in the pre-implantation embryo. Additionally, 
there is some long-range regulation from chromosome 7 transposable element (TE) 
expression: these piRNAs can target pit-RNA and stop methylation. Unlike the other 
paternal ICRs, methylation here involves PIWI-interacting RNAs (piRNAs), a different 
kind of ncRNA that is transcribed from intergenic piRNA clusters found among various 
TEs. 
As alluded to, repetitive elements contribute to paternal imprinting and survival of 
offspring. While there should be global de-methylation in maternal and paternal 
primordial germ cells (PGCs) before re-establishment of sex-specific imprints, mice 
paternal intra-cisternal A particle long terminal repeat promoter retrotransposons (IAP 
LTRs), Line1, and minor satellites are only partially de-methylated. Substantial 
methylation is retained by IAP LTRs in paternal germ cells at E12.5, during the period of 
global de-methylation when imprints should be erased, compared to their maternal 
counterparts (Figure 6). This is also true of Line1 and minor satellites at E12.5. Why they 
are never completely de-methylated has been proposed to function as a safeguard against 
re-activation of TEs. Furthermore, these repetitive elements increase in methylation 
between E15.5 and E17.5 via de novo methylation during the period that sex-specific 
imprints are established and during post-fertilization re-methylation, when there is 
paternal re-methylation 20,21. Histone methyltransferase SETDB1 is said to mediate H3K9 
trimethylation at partially methylated retrotransposons, and its expression is crucial for 
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proper gonad development in both sexes 22. Kato et al. (2007) observed short interspersed 
nuclear element B1 (SineB1) and major satellite (pericentric repeat) elements are also de 
novo methylated between E12.5 and the newborn stage. Maternal imprints, as mentioned 
before, are not heavy in IAP LTRs; and the IAP LTRs that are present in the maternal 
genome do not undergo de novo methylation during E12.5 and E17.5.  
Figure 6. Methylation Status of Repetitive DNA elements between Parental Lines 21. 
 
In accordance with the “host defense hypothesis,” many of these TEs are 
routinely silenced by piRNA mechanisms to repress their potentially deleterious effects 
23,24. Piwi proteins are involved in these piRNA mechanisms, and their loss results in 
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germline-specific apoptosis thought to be triggered by DNA damage induced by high 
levels of TE transcripts 9. This loss of fertility and embryogenesis illustrate that piRNAs 
have also evolved a critical function in gametogenesis and imprinting. Both PIWI 
proteins and piRNAs are expressed predominately in the male gonads of a wide range of 
eukaryotes, including humans 25. In the Drosophila, three PIWI proteins are essential for 
germ cell development. Without aub (mouse ortholog: MILI) or piwi (mouse ortholog: 
MIWI), male and female fertility was compromised; without ago3 (mouse ortholog: 
MIWI2), only female fertility was compromised 9,26.  
In mice, PIWI proteins seem to be asymmetrically distributed between the two 
sexes. All three PIWI proteins are expressed at different stages during spermatogenesis, 
while MILI is expressed weakly in maternal germ cells. This paternal dependence on 
PIWI is demonstrated by differences in impact on germ cell production between the two 
sexes in PIWI mutants 27. Furthermore, deficiency in MILI or MIWI2 leads to the 
activation of long interspersed nuclear elements (LINEs) and long terminal repeat (LTR) 
retrotransposons, including L1 and IAP elements, causing arrest of spermatogenesis at 
the early spermatid stage 28. In the absence of MILI, production of secondary cytoplasmic 
piRNAs that load onto MIWI2 is impaired; thus, nuclear localization and import of 
MIWI2 does not occur and de novo methylation of TEs cannot occur (Figure 7b)23. It is 
notable that MIWI2 is detected at high levels in the nuclei of 18 dpc (days post-coitum) 
male gonocytes through 3 dpp (days post-partum) spermatogonia stem cells—this overlap 
in timeline and expression suggests MIWI2’s involvement in imprinting9. piRNAs are 
facilitators in this process, and therefore, are a crucial factor to de novo methylation and 
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transposon silencing. Different PIWI proteins are said to be involved in different stages 
of spermatogenesis (Figure 7a.) and imprint maintenance (e.g. MIWI and MILI for L1 
silencing in mouse testes), and therefore bring an important consideration to the 
establishment of paternal genomes and m2. 
Figure 7. piRNA regulation of spermatogenesis and de novo methylation 9
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Analogous to mice, Drosophila Piwi localizes to the nucleus to epigenetically 
silence genes 9. Once piRNAs complementary to TEs are transcribed and processed, they 
are transported into the cytoplasm 29. Here, they are further processed, loaded onto Piwi, 
and are further modified in the Piwi-piRNA complex. The complex now enters the 
nucleus to modify histones (e.g. H3K9me3) and associates with Pol II of target genes, 
inducing a closed chromatin state and downregulation of gene expression in the region 
30,31. Additionally, nuclear protein Asterix/DmGTSF1/Arx (mouse ortholog: GTSF1) 
associates with the Piwi-piRNA complex to mediate histone methylation. Mael, other 
histone methyltransferases Egg/ SetDB1 (mouse ortholog: SETDB1/ SETDB2), and 
heterochromatin protein HP1a are also involved with Piwi-piRNA complex transposon 
silencing 9,32. Pal-Bhadra et al. (2004) shows that in Piwi and aub mutants, 
heterochromatin protein HPI1 and HP2, components of piRNA clusters, are de-localized 
and H3K9me marks at transgenic loci are reduced. 
More interestingly, studies around “hybrid dysgenesis” in the Drosophila caution 
us of asymmetric inheritance of cytoplasmic factors that could affect imprinting. If there 
are two flies of the same species, the mother codes for a transposon while the father does 
not—their progeny survives as a “reciprocal cross;” 47. In contrast, if a father has a 
transposon in his genome and the mother does not, this will result in a “sterile 
phenotype.” This is because piRNAs are preferentially expressed and utilized in the 
female germline in Drosophila 31. Aub, a Drosophila PIWI protein, is localized to the 
posterior pole of the oocyte and embryo 9. Aub complexes with piRNA to function like 
the immune system, targeting once-exogenous transposons. Without cytoplasmic 
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inheritance from the Piwi-piRNA-endowed mother, the progeny is vulnerable to 
transposon attack inherited from the father. Therefore, small, cytoplasmic RNAs (e.g. 
piRNAs) themselves serve as vectors for epigenetic information, and appear necessary 
for reproductive competence 33. While in mice, piRNA-PIWI complex expression leans 
paternally, this model of dysgenesis is still insightful. 
In contrast to the host defense theory, various TEs are under-methylated in the 
maternal line during the early stages of development and are thought to improve the 
fitness of the mother. Transposable elements MT-LTR and MuERV-L LTR act as 
alternative, cell-specific promoters during oocyte maturation and during 2-cell stage, 
post-embryonic genomic activation and blastocyst pre-implantation development, 
respectively 48. Although only 5% of classic developmental genes are upregulated by 
these promoters, they prove to be essential. MuERV-L LTRs, for example, appear to 
drive pluripotency during the 2-cell stage 35.  
DNMT1 and Hells (Lymphoid-specific helicase LSH) act as regulators between 
stages of embryonic development, silencing these alternative, maternal TE promoters 34. 
Silencing these promoters can be done directly by upregulating MILI and their associated 
pi-RNA complexes that recognize TE loci and initiate methylation or by upregulating 
KRAB zinc finger proteins (KRAB-ZFPs) that recruit TRIM28 (KAP1) complexes to 
modify H3 histones (e.g. trimethylation) and induce closed chromatin states38,48. From 
mice knockout studies, it has been confirmed that Trim28 and its effector Setdb1 have 
also been shown to repress several ERVs 22,34. Furthermore, tRNA-Gly-GCC, 5’ tRNA 
fragments (tRFs) derived from epididymosomes that traffic to maturing sperm during 
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spermatogenesis, are said to repress genes associated with retrotransposon MuERV-L in 
the nascent zygote 36—adding to our list of cytoplasmic imprint regulators. Other 
cytoplasmic factors like Prm1 that are synthesized during testicular spermatogenesis and 
function in the later stages of spermatogenesis 36 will be discussed further on. 
Our final discussion of paternally-imprinted elements involves a brief review of 
minor and major satellite sequences. Minor satellite sequences are found in tandem 
repeats, localized to centromeric positions and are not encoded by DNA nor transcribed21. 
Minor satellite sequences are thought to be important in centromere function and 
kinetochore assembly involved in chromosome segregation during mitosis. Major 
satellites, on the other hand, also play a role in chromosome segregation but consist of 
pericentric repeats and cluster with accumulated heterochromatin protein 1α (HP1α) 21,23. 
Major and minor satellites display asynchronous replication and segregation during cell 
cycle—it is said that this spatio-temporal organization between major and minor satellites 
is critical to maintaining proper kinetochore function with coordination between the 
centromeric cohesion and dissociation necessary for chromosome segregation37. 
Both major and minor satellites have methylated H3K9, but major satellites seem 
to have a distinct, higher order chromatin structure, inclusive of dinucleosomes37. 
Regarding temporal regulation, prolonged cohesion in major satellites is lost in the 
absence of Suv39h histone methyltransferase. This seems to be the predominant agent in 
methylating major satellites, as proven by studies on mutant Dnmt1 single (-) or 
Dnmt3A/Dnmt3B (-/-) mouse embryonic stem cells37. The Dnmts will be discussed later, 
but it should be known that Dnmt3B establishes paternal imprinting on satellite repeats6. 
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Lehnertz et al. (2003) supports findings by the Guenatri et al. (2004) study: in vivo, 
Dnmt3B interacts with HP1α at heterochromatic foci, but it is Suv39h that ultimately 
directs H3K9 tri-methylation and Dnmt3B-dependent DNA methylation at pericentric 
repeats. These factors become relevant in our discussion of satellite de-repression and the 
consequential, very rare autosomal recessive Immunodeficiency, Centromere instability 
and Facial Anomalies syndrome (ICF syndrome) that can develop. 
 
m2 Germ Cell with Paternal Epigenetic Reprogramming  
Since viability of offspring depends on the balanced expression of imprinted 
genes and other imprinting regulatory factors between maternal and paternal epigenomes, 
it would be ideal to create a “paternal epigenetic scaffold.” Determination of this scaffold 
should be further inquired, looking at the epigenomes of screened healthy males, with 
minimal two-generation history of famine, significant health conditions, and infertility, at 
the least. MeDIP procedures and promoter arrays could be used to examine methylation 
profiles, as was done in the Hammoud et al. (2009) study, in addition with evaluation of 
other epigenetic modifications and overall chromatin structure. With discussion of 
paternal imprints, non-coding RNA, microsatellites, and other silenced elements, 
methylation profiles can be assessed for quality, looking for analogous methylation 
markers found in paternal mice. With the correct epigenome, this “scaffold” can be 
imprinted upon the genome of a de-methylated non-growing oocyte (m2) that has 
undergone multiple passages38. The m2 nuclei, nuclei taken from demethylated oocytes 
that have undergone multiple passes of in vitro culturing, could be injected using 
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pronuclear transfer into m1, the other fully grown (MII) maternal oocyte, and 
subsequently reactivated by a calcium or strontium chloride solution. Before methods for 
targeting this “scaffold” can be discussed, in vivo mechanisms of de-methylation and 
imprint establishment and maintenance are detailed below. 
Imprint Establishment and Reprogramming Overview 
The status of an imprint depends on the type of germ cell and the life stage of the 
germ cell and organism. Unlike somatic epigenomes, where DNA methylation patterns 
inherited by daughter cells tend to be stable throughout life, imprints are stripped and re-
established (Figure 8) once during epigenetic reprogramming in mammalian primordial 
germ cells (PGCs) to re-establish totipotency and reflect the sex of the future parent (e.g. 
X chromosome can be re-activated in female germ line), and once in early embryos to 
enable proper development (Figure 9). The initial reprogramming event is thought to 
prevent the accumulation of potentially detrimental epialleles which could otherwise 
cause chronic disease and limit lifespan in human populations. Not carefully 
reconstructing the epigenome in germline cells, for example in TET -/- mice, result in 
placental and fetal growth defects and high rates of embryonic death 39. Exceptions to 
global and complete de-methylation are repetitive elements, as they could reactivate and 
cause damage, resulting in cellular apoptosis of germ cells. Protected methylation sites 
during these reprogramming events may include the piRNA mediated methylation and 
histone methyltransferase SETDB1-H3K9me3 modifications at TE loci and adjacent 
CpG islands discussed earlier. 
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Figure 8. Level of Global DNA Methylation Between Gametes 40 
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Figure 9. Methylation-De-methylation Status in the Lifecycle of the Mouse 41. 
 
Global Demethylation (E6.5-13.5) 
As reviewed by Murphy et al. (2014), PGCs, the precursors to germ cells, are 
“specified” in the mouse between embryonic day (E) 6.25-7.25, when a subpopulation of 
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somatic epiblast cells express select transcription factors that set them apart from 
neighboring cells. Between E7.5 and E10.5, founder PGCs proliferate and migrate, erase 
their H3K9me2 mark, pause at the G2 cell cycle, acquire a H3K27me3 mark, and resume 
progression through the cell cycle on their way to the genital ridge where the future 
gonads of the embryo will develop 42. During this migration, epigenetic reprogramming 
and re-establishment of totipotency in the germline is initiated. This “swapping” process 
is facilitated by Prdm14 germ cell transcription factor, which represses H3K9 di-
methyltransferase Ehmt1 until ~E13.5-14.5, allowing for passive de-methylation. In 
Drosophila melanogaster, the chromatin signature is further modified by UTX, a JmjC-
domain containing demethylase that displaces the polycomb repressive complex (PRC2) 
that maintains H3K27 trimethylation marks on developmental genes40 (note: both UTX 
and PRC2 are conserved in humans but the former is known as KDM6A lysine 
demethylase). UTX associates with H3K4 methyltransferases to add H3K4me3 marks43 
nearby transcriptional start sites, poising developmental transcription factor gene 
expression delicately in a non-repressed yet non-active state. These bivalent H3K27me3 
and H3K4me3 marks are proposed to prime the loci for expression or repression during 
embryonic stem cell differentiation, depending on how they are altered13. Achieving the 
correct chromatin signature during this time is critical to formation of a viable zygote. 
This seems to be of particular importance in the male germline cells, as deletion of PRC2 
of Drosophila led to failed meiosis and infertility40. This coincides with the genome-wide 
studies on mature sperm in human and mice, which consistently have these bivalent 
H3K27me3 and H3K4me3 marks at particular developmental promoters44. It seems that 
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without the distinct paternal epigenetic signature provided by male germ cells, and 
necessary enzymes and co-factors for its maintenance, embryological development is 
hindered. 
Returning to our description of global de-methylation, by E8 and E9.5, 70% of 
methyl marks are erased. Those that remain are the DMRs of imprinted loci, X-linked 
loci, and meiosis- and sperm-specific genes, which are only de-methylated after E10.5, 
when PGCs enter the genital ridges 26. At E12.0, the bi-potential gonad differentiates 
down the testis or ovarian path, germ cells receiving sex-specific signaling from somatic 
cells 45. Still, global methylation levels continue to fall to their lowest: 14% and 7% by 
E13.5 in male and female germ cells, respectively 46. Yamaguchi et al. (2013) found that 
at this time in development, some imprinted genes are significantly upregulated in 
expression in both male and female PGCs, which is expected during this germline de-
methylation. 
As described by Kagiwada et al. (2013), DNA de-methylation is a largely passive 
and replication-dependent mechanism, especially in the beginning stages of 
embryogenesis. Levels of Dnmt3A, Dnmt3B, and Dnmt3L are found to be very low prior 
to E12.5, which indicates a lack of de novo methylation. Additionally, Uhrf1, a 
recruitment factor for the maintenance methyltransferase Dnmt1 is repressed in PGCs 
and cannot operate during E10.5-13.5 47. Between E9.5-E13.5, active mechanisms of de-
methylation seem to pick up as methylcytosine dioxygenases ten-eleven translocation 1 
(TET1), TET2, and various base excision repair (BER) proteins appear in germ cells 47. 
TET primes the methylated site for BER proteins to work on: 5-methylcytosine (5-mc) is 
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converted to 5-hydroxymethylcytosine (5-hmc) and the BER pathway replaces the 
intermediate 5-hmc with a completely un-methylated cytosine. The peak of 5-hmc at 
E11.5 corresponds with the subsequent trough of global methylation at E13.5 48. It should 
be noted that TET1 utility may be limited to de-methylation at specific loci 40. Before 
delving into the asymmetrical establishment of imprints, it should also be noted that there 
is incongruence in stages of development between pre-imprinted gametes. During E13.5-
14.5, the non-dividing maternal germ cell enters meiosis and arrests in prophase I as a 
primary oocyte while prospermatogonia enter a period of mitotic arrest 40. 
	
Establishment of Sex-specific Imprints (E.15.5- E.17.5/ postpartum) 
De novo DNA methylation is mediated by Dnmt3A, Dnmt3B, and Dnmt3L. 
These enzymes establish sex-specific DNA methylation at imprinted genes, single-copy 
genes, and repeat elements in germ cells 40. In humans and mice, Dnmt3A is essential for 
maternal imprinting 49 and establishing the following paternal imprints: H19, Dlk1/Gtl2, 
and some of Rasgrf1 DMR; short interspersed repeat SineB1; endogenous retrovirus 
intra-cisternal A particle (IAP); and long interspersed nuclear element (Line1) 37,64,65. It is 
suggested that Dnmt3A2 and Dnmt3L are specifically responsible for the de novo 
methylation that occurs in sperm, as these isoforms are predominantly found in 
prospermatogonia52. Dnmt3B, on the other hand, establishes paternal imprinting on 
satellite repeats, and have overlap in imprinting over the paternal Rasgrf1 DMR, long 
interspersed repeats IAP, and LINE1 6,23. Although expressed in higher levels later in the 
time course than Dnmt3A52, Dnmt3B is important in suppressing ICF, a disease that 
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precipitates when there is de-methylation of classical satellite 2 and satellite 3 in almost 
all tissues, heterochromatin is destabilized and there is the formation of aberrant 
chromosomes 21,53. Ultimately, this lowers serum immunoglobulin levels, making it 
difficult for patients to live to adulthood. 
Because sufficient methylation at imprinted loci is required for developmental 
competence, it is important to ensure that the hypothetical m2 germ cell will express the 
proper levels of necessary enzymes. This elucidates how maternal factors can “protect” 
against male imprinting in females and comprises one mechanism of differential 
imprinting. With this in mind, it seems that removing the protective factors in the m2 
ovum could permit the action of methylation enzymes to act at male imprint sites and 
create a viable paternal epigenome. This is premature to state because the targeting 
mechanisms of Dnmt3A and Dnmt3B are still unknown. However, what is known is that 
Dnmt3L is necessary for imprinting and is expressed and in both sexes. 
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Figure 10. Levels of Methylation and DNMT3L Expression in Male and Female 
Germ Lines 3. 
 
Maternal imprints are established later in life during the post-natal oocyte growth 
period, a few days before ovulation when Dnmt3L levels rise in expression 3,23. Although 
Dnmt3L lacks the catalytic domains to fix methyl groups to the fifth position of a 
cytosine carbon ring like the de novo methyltransferases Dnmt3A and Dnmt3B, it is 
essential in coordinating DMR de novo methylation in maternal imprints 37,56—the 
exception to this Dnmt3L requirement is with de novo methylation of IAP elements in the 
growing oocyte 21. The necessity and specificity of Dnmt3L for parental methylation has 
been illustrated through Dnmt3L -/- mutant oocytes 54. Loss of methylation was restricted 
to imprinted regions as global genome methylation levels remained unaffected in 
homozygous Dnmt3L -/- mutant oocytes. Furthermore, Dnmt3L -/- mutation in oocytes 
caused bi-allelic expression of PEGs in offspring, resulting in mid-gestational death. 
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Aside, from de novo methylation, Dnmt3L interaction with Dnmt3A has also been said to 
recruit histone deacetylases (HDACs) and cause subsequent co-repression of loci. 
Rousseaux et al. (2005) suggests that these interactions may be important for setting-up 
sex-specific genomic imprints. 
Table 1. Various Aspects of Sexual Dimorphism in Parental Imprint Ontogeny and 
Contribution to Embryonic Development 3. 
 
 
Comparatively, paternal imprints are established early on in perinatal 
prospermatogonia, as shown by Dnmt3L levels in Figure 10. Re-methylation of 
paternally-imprinted genes begins around E15.5 during spermatogenesis in fetal, 
mitotically-arrested prospermatogonia, and is completed only after birth23,55–58. Li et al. 
(2004) argues that de novo methylation of Rasgrf1, Gtl2, and H19 begins in parallel, as 
early as E12.5 and is completed by birth. This seems to take on a different methylation 
program from that of paternal IAP, L1, and minor satellite sequences that quickly become 
fully methylated by E17.5. Regardless, methylation at these sites peak before the onset of 
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meiotic prophase I. This indicates complete imprint establishment, and subsequently 
allows for the proper pairing of chromosomes during meiosis40. 
Assessment of mouse Dnmt3L -/- male germ cells at 17 dpp  in the Bourc’his & 
Bestor (2004) study show a dimorphic difference in dependence on Dnmt3L for perinatal 
DMR methylation: Dnmt3L is necessary for the heritable silencing of IAP and Line1 
elements, specifically, in male germ cells. Those deficient in Dnmt3L show 
hypomethylation at IAP and Line1 elements and result in meiotic synaptonemal 
dysregulation, whereas Dnmt3L -/- female germ cells show no aberration in meiosis nor 
hypomethylation at these sites. Interestingly, this study found that paternal DMR Dlk1/ 
Gtl2 does not rely on Dnmt3L at all and H19 DMR only shows 50% dependence on the 
enzyme. Unfortunately, Rasgrf1 DMR was not assessed in this study. It has been 
suggested by Kato et al. (2007) that IAP and Line1 elements share structural similarities 
to Rasgrf1. Assessing Rasgrf1 DMR methylation status in Dnmt3L -/- male germ cells 
could have confirmed another level of overlap in the network of imprinting regulation. 
Nonetheless, it was demonstrated that Dnmt3L mutants show no impact on the piRNA 
production 60, which may leave Rasgrf1 properly methylated, given there is proper 
expression of Dmnt3A and Dnmt3B. Interestingly, it was suggested that although 
Dnmt3L levels do impact methylation, it itself does not play a direct role in in paternal 
methylation so much as performing a scan of the genome during the perinatal period to 
ensure silencing of retrotransposons before meiosis resumes 59.  
During this period of methylation establishment, high levels of H3K4me3 are 
established in sperm17. As mentioned previously, H3K4me3 and H3K27me3 bivalent 
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modifications transmitted from mature sperm establish pluripotency in the future embryo. 
The Hammoud et al. study (2009) provided evidence for this when they found that 
embryonic stem cells had a very significant overlap of bivalently-marked genes in sperm. 
Through methylated DNA immunoprecipitation (MeDIP) procedure and promoter arrays, 
they found DNA hypo-methylated promoters in mature sperm overlapping with 
developmental promoters bound by the self-renewal network of transcription factors in 
human ES cells (e.g. OCT4, SOX2, NANOG, KLF4, and FOXD3 proteins). Prominent 
blocks of H3K4me3/2 were clearly observed at imprinted genes and at all developmental 
HOX loci, encoding multiple ncRNAs expressed during embryonic development17. 
Table 2. DNA methylation maintenance13. 
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The different nuclear chromatin and protein composition of prospermatogonia and 
growing oocytes, also seem to provide a scaffold for the differential methylation of 
paternal and maternal ICRs in each parental germ line3.  Proteins that act on paternal 
chromatin include the nucleosome remodeling and deacetylase’ (NuRD) complex, 
composed of proteins like MBD3 and metastasis tumor antigen-2 (MTA2), and H1 linker 
histones, which both contribute specifically to paternal imprinting at H19/ Igf2.  
Because of their involvement in regulation of meiosis and spermiogenesis, 
paternal imprints are completed by the spermatogonia stage and conserved thereafter (see 
Figure 11) 65. Global chromatin is also remodeled during this time. First, histone variants 
such as H2A.X, acetylated forms of H4 as well as un-acetylated forms, H3.1, banded 
H3.3, and banded H2B are incorporated into the DNA (see Figure 12)61.  This is 
facilitated by H3K4me3 methylation40. Second, core histones are hyper-acetylated during 
spermiogenesis, the final maturation phase of spermatogenesis that revolves around 
structural and morphological changes in round spermatids61. The hyper-acetylation 
signals for the replacement of core histones by transition proteins and protamines which 
ultimately allow for nuclear condensation and elongation for spermatozoan protection 
and motility. 
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Figure 11. Imprint Status of Sperm, Paternal PGCs, and Embryonic Cells 58. 
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Figure 12. Localized modifications associated with erasure and setting up of male-
specific imprints) 61. 
	
	34 
Prm1 and Prm2, the sole protamines found in mice and human sperm nuclei, are 
thought to contribute to a unique heterogenous, dual nucleoprotamine-nucleohistone 
structure that enables maintenance of sperm chromatin and embryo viability past the 
blastocyst stage61. The structure of nucleoprotamine is significantly different from that of 
nucleosomes in that there is essentially complete neutralization of the negative charge on 
DNA by basic amino acids, allowing for its compaction. Although Prm1 and Prm2 may 
not be specific to the protection of imprinting, these proteins maintain a condensed 
chromatin structure that protect against nuclear damage and alteration of paternal 
imprints. 
Chromatin remodeling plays a role beyond compaction and transportation of a 
delicately imprinted genome though (see Table 3). Although imprints are complete by the 
end of the spermatogonia stage (with the exception of Gtl2-DMR), mature sperm contain 
some epigenetic modifications that confer developmental competence. This is evidenced 
by Kishigami et al. (2006) whose mouse embryos developed from round spermatid 
injections (ROSI) failed to produce comparable reproductive outcomes to injections using 
mature spermatozoa (ICSI). It seems that chromatin modifications like histone-protamine 
exchange and the correct degree of acetylation on specific histone residues enable proper 
epigenetic programming of the zygote. Improper paternal epigenetic modifications and its 
resulting chromatin structure disrupts maintenance of un-methylated/ methylated states in 
the paternal pronuclei of the growing zygote. Overall, these differences in chromatin and 
protein factors between male and female sexes, in addition to the different de novo 
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methylation timeline, create a surmountable barrier to achieving creation of a viable m2 
germ cell. 
Post-fertilization, Selective Erasure 
In the mouse and human, the paternal genome in the zygote is widely de-
methylated after fertilization—imprints excluded from this erasure—and remains un-
methylated until right before DNA replication62. In mice, this occurs within only a few 
hours (by ICSI, 6–8 hours post-fertilization 63; see Figure 14) and in a highly coordinated 
fashion as the zygote proceeds through the first G1 phase 64. Meanwhile, H3K9 of the 
maternal genome is thought to be highly di- and tri-methylated as it progresses from 
mature oocyte to the four-cell stage63. Suv39H and HP1-Beta both maintain H3K9me3 at 
constitutive heterochromatin at pericentric regions in the maternal pronuclei65. 
Global de-methylation at this stage follows a pattern of de-methylation unlike that 
seen in PGCs. Aside from the “asymmetrical erasure” between male and female 
pronuclei that occurs post-fertilization, de-methylation in PGCs is largely passive and 
replication-dependent, resulting in a continual loss of methylation during this time of 
spurting growth. In the zygote, the first cell division is the only time de-methylation 
occurs through passive, replication-dependent mechanisms66. Elongator complex proteins 
(ELPs) have been implicated in de-methylation of the paternal genome, as it is involved 
in multiple aspects of transcriptional regulation and can modify tRNAs41. Enhancement 
of chromatin bound XRCC1 in the paternal pronucleus has also been noted41. The rest of 
de-methylation results from active mechanisms inclusive of BER, TET3, and some other 
unknown factors66. 
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TET3 works simultaneously during DNA replication in the same manner that 
TET1 and TET2 do in PGCs, through oxidation of 5-mc to 5-hmc coupled with AID and 
BER repair mechanisms66. However, TET3 goes on to contribute to “asymmetrical 
erasure.” Not only does TET3 catalyze de-methylation at intergenic regions, gene bodies, 
and non-CpG containing promoters in the paternal line, but TET3 actually protects loci 
against de novo methylation at particular promoter CpG islands67. 
Paternal de-methylation at certain loci, and thus TET3, is crucial for continuing 
past mid-gestational development as zygotic gene activation and pre-implantation 
development resultingly remain intact40. Also, it seems that the maternal germ cell 
contributes some of the necessary enzymes to continue through development, as maternal 
deficiency of TET3 impedes the de-methylation process of paternal Oct4 and Nanog 
genes and delays the subsequent activation of a paternally-derived Oct4 transgene in 
early embryos68. Note that global methylation reaches another low in the inner cell mass 
by E3.5 (Figure 8)40. 
As previously mentioned, de-methylation during this stage of development is not 
complete, as it is critical to maintain parental imprints during the first embryonic cell 
divisions. High levels of oocyte proteins such as DPPA3 (Stella or PGC7) have shown to 
be involved in maternal ICR methylation maintenance in through embryonic 
development, in the methylation maintenance of two paternal ICRs in the early embryo, 
and in the early embryo pluripotent cells 69. When localized to the nucleus, DPPA3 can 
block conversion of 5mC to 5hmC. In fact, DPPA3 accounts for the delayed de-
methylation of the maternal genome after fertilization. 
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As reviewed by Sanli & Feil (2015), other proteins that support methylation 
maintenance in ES cells include specific lysine methyltransferases (KMTs, e.g. G9a and 
ESET/SETDB1 that target H3K9) and the KRAB-domain zinc finger protein ZFP57. 
ZFP57 recruits KAP1 (TRIM28 or TIF1B) 70 that sequentially recruits histone-modifying 
enzymes like ESET/ SETDB1 71. ZFP57 recognizes the sequence ‘TGCCGC’ found at 
H3K9me3-bearing, DNA-methylated allele of ICRs to maintain methylation 72. 
 
Re-methylation in Male Pronuclei 
 
In the paternal pronucleus, de novo methylation between E15.5 and E17.5 results 
in complete methylation of repeat sequences, which is not seen in the maternal 
pronucleus21.While de novo methylation does not occur in the maternal pronuclei at this 
time, histones with H3K9me3 are being maintained by SUV39h, HP1-Beta, and DPPA3. 
The paternal pronucleus, without these proteins, is found with H3K27me3 at its 
pericentric heterochromatin65. Maternal factors are partly responsible for inducing 
asymmetrical changes in pronuclei, as maternally-supplied PRC1 (e.g. ring finger protein 
2 (RNF2)) catalyzes H3K27 methylation at paternal pericentric heterochromatin73. Other 
players such as CBX2, chromobox homolog 2, target active PRC1 to paternal sites to 
maintain methylation, while HP1-Beta and H3K9me3 protects maternal sites against 
CBX2 targeting74. 
Also key to asymmetrical reprogramming are the prerequisites for PRC1: it needs 
to recognize both heterochromatin lacking H3K9me3 and the absence of SUV39h before 
catalyzing H3K27 methylation73. Note that similar mechanism of reprogramming occurs 
with euchromatin between the parental lines: PRC1 components are necessary for 
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repression of paternal loci, but also involve PRC1-recruitment factor PRC2. Without 
these maternal factors, there is unregulated expression of paternal major satellites, 
leading to ICF syndrome and lethality. Additionally, the promoter of Igf2r (mouse MEG) 
have been shown to increase in methylation during this time75. Alteration in expression of 
this gene has been association with risk of hepatocellular carcinoma. 
Once methylation marks have been established, maintenance DNA 
methyltransferases (e.g. DNMT1) can maintain these modifications through cell division, 
pre-implantation development, and embryogenesis59. DNMT1 acts on hemi-methylated 
sequences, with the aid of recruitment factors UHRF1 (Np95), DAXX, hNaa10p, STAT3, 
Kcnq1ot1 ncRNA and interacting factors SET7, LSD1, HP1, HDAC1/2, G9a, and 
AKT176. Note that DNMT3L is not needed for maintenance methylation. 
Parental epigenetic asymmetry is said to be resolved by the end of the 8-cell 
stage. This coincides with findings in vivo that the total amount of DNA 
methyltransferase activity remains constant until the 8-cell stage, after which it 
decreases77. This is also concurrent with blastomere polarization—marking the end of the 
maternal-to-embryonic transition78 While achieving and maintaining the correct 
methylation patterns across bi-parental ICRs until the 8-cell stage sounds attainable in the 
grand scheme of growth and development, the unique combination of methylation, 
chromatin conformation, and cytoplasmic factors required from maternal and paternal 
lines must be met at each successive step, which is likely difficult to reprogram into an 
m2 germ cell. 
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Global De-methylation: Resetting the m2 Epigenome 
In order to successfully establish the paternal imprint onto m2, global and complete de-
methylation of the m2 genome must occur. Because of the low levels of global 
methylation, it would be preferable to utilize a non-growing (<60 um in diameter), 
secondary oocyte in metaphase II (MII). To ensure that the maternal imprint would be 
completely replaced with the paternal imprint, active facilitators of de-methylation, TET1 
and TET2, could be added to cultures of non-growing secondary oocytes. A concern is 
the viability of a completely de-methylated female germ cell. Activation of 
retrotransposons by de-methylation could induce apoptosis. A monumental study by Li et 
al. (2018), not only illustrated the viability of de-methylated female PGC cultures, but 
demonstrated viability of offspring derived from parthenogenetic haploid embryonic stem 
cells (phESCs). While it may be ideal to harvest PGCs or ESCs to create an m2 germ 
cell, there would be more ethical barriers performing such a procedure in a young human 
embryo. Additionally, harvesting cells from an embryo does not promote reproductive 
autonomy for AFAB couples as this research is intended to do. As an alternative, the 
generation of haploid SCNT (somatic cell nuclear transfer)-mediated totipotent cells may 
be used to reset methylation levels. In accordance with SCNT protocols detailed by 
Tachibana et al. (2013), generation of human nuclear-transfer ESC cells would involve 
the use of envelope from an inactivated hemagglutinating virus of Japan (HVJ-E) to fuse 
nuclear donor cells with enucleated MII oocytes while maintaining cytoplasts in meiosis, 
the careful and timely removal of MII spindle, the use of caffeine during spindle removal 
and somatic cell fusion, the application of electroporation/DMAP (ionophore used to 
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raise intracellular levels of calcium),	tapered doses of trichostatin A, plating on MEF 
medium and manual passaging123. Tachibana et al. (2013) protocols take into 
consideration how unstable the meiotic arrest state MII oocytes are in and how removal 
of oocyte’s nuclear material disrupts the cell’s ability to induce reprogramming123. Chung 
et al. (2014), utilizing Tachibana et al.’s SCNT protocol, proved that generation of human 
haploid ESCs are even possible from older donors (35 and 75 year-old males) rather than 
fetal donors. It was observed that with reversion to a totipotency state, cells lengthen their 
telomeres and become “rejuvenated”122. 
 The source of donor cell and donor nucleus for the reprogrammed m2 cell would 
be derived from the same donor. The cell type of the donor nucleus could be drawn from 
blood or taken from biopsy, as induced pluripotent stem cells (iPSCs) are commonly 
derived from blood cells and fibroblasts. There was concern previously that although 
induced pluripotent stem cells could be genetically identical, iPSCs could have varying 
transcriptional and epigenetic patterns, having gone through different differentiation in 
their maturation. These unaccounted differences could impact the iPSCs of different 
origin and their capacity and efficiency to differentiate into different-from-origin defined 
cell lineages. The study by Polo et al. (2010) showed that the observed differences in 
epigenetic and gene expression between iPSCs of different origin were attenuated by the 
continual passaging of iPSCs. Differences in gene expression dropped as low as 0-5 
genes by late passage (p16)121. In agreement with the study, it seems that complete 
reprogramming of a cell requires, aside from pluripotency genes being expressed, time to 
slowly adjust and modify its epigenome (demethylate). Polo et al. (2010) had employed a 
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different method of achieving iPSCs that did not involve SCNT protocol; instead they 
used OSKM induction, the upregulation of Oct4, Sox2, Klf4, and c-myc transcription 
factors via Doxycycline-inducible Lentiviruses coding for these four transcription factors. 
This approach to attaining demethylated cells for precursor m2 cells could prove as an 
alternative as well. Shinagawa et al. (2014) was able to improve upon OSKM iPSC 
production by adding histones TH2A and TH2B, which are naturally expressed in high 
levels in oocytes and contribute to activation of the paternal genome post-fertilization125. 
TH2A and TH2B, as well as depletion of Xist in combination with SCNT and OSKM 
techniques, enhanced reprogramming efficiency of iPSCs125. Developmental potential 
could further improve depleting microRNA miR-34a, which strongly induces expression 
of endogenous retroviral MuERV-L126. As discussed earlier, expression of this promoter 
drives early pluripotency of the developing embryo. Some final considerations for 
generation of demethylated precursor m2 cells would include the chemical methods of 
Efe and Ding (2011) and Zhao et al. (2015)127,128. As a final consideration in generating 
human iPSCs, sources of cells as well as produced cells should be monitored with quality 
control tests, tumorigenicity assays, and genomic integrity validation should be used to 
evaluate the propensity for tumor genesis before its clinical application129.  
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Figure 13. Passaging May Permit Complete Demethylation of iPSCs121 
 
Imprint Targeting 
Knowing that there is some overlap in expression of de novo methylation 
enzymes in male and female germ cells49, the question then revolves around how imprint 
acquisition can be targeted. Apparently, there are histone-guided mechanisms for the 
establishment of DNA methylation79,80. Going back to the basics of epigenetics, 
methylation status of H3K9 or H3K412 determines whether or not de novo methylation 
machinery has access to the ICR region81,61,82 and whether there will be transcription 
	43 
through the ICR region. H3K4 methylation prevents the DNMT3A2/DMNT3L complex 
from binding 83, so targeting enzymes to remove H3K9me3 from maternally-expressed 
genes and non-coding RNAs and establish H3K4me2/me3 could induce chromatin 
remodeling in m2 at maternally-methylated ICRs. To not attain the correct chromatin 
structure in the m2 would put the embryo at risk of multiple developmental 
abnormalities: 
Table 3. Distinct chromatin sperm packages for embryo development17. 
 
 
As methylation patterns are established, maternal ICRs in the male germ cells are 
concurrently protected against the acquisition of methylation. Protection begins from 
when the male germ cells are PGCs and continues onward 51. CTCF also seems to have a 
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role here. Not only is it involved in repressing un-methylated ICRs, but it also protects 
against de novo methylation (see Table 2. Factors that prevent against de novo 
methylation79). It is also purported that OCT4 and SOX2, pluripotency transcription 
factors, aid in CTCF protection against methylation at maternal ICRs85. If these 
protective mechanisms could be extrapolated and applied to m2, there may be an increase 
in reproductive competence. It has been observed that maternal ICR methylation within 
the male germ cell results in oligozoospermia17. Imprinting defects in paternal genome is 
not restricted to improper methylation at the paternal ICR, and thus, more precautions 
and interventions must be taken when establishing the m2 “paternal scaffold” epigenome.  
Even if we achieve the correct epigenome for fertilization and early pre-
implantation development—the correct epigenetic “scaffolding” from pre-meoitic, 
mature sperm—how is maintenance to be implemented? How do we get DNMT1, 
common to both sexes, to work according to their sex-specific, paternal program?  It has 
been noted in the early female embryo that maternal miRNAs (e.g. miR-29b) help with 
suppression of Dnmt3A and Dnmt3B during E.13.5- E.17.5 when the sperm imprints are 
established 66. Will the paternal “scaffold” repress expression of these miRNAs and 
protect itself against erasure? It is also important to note that imprint establishment and 
maintenance enzymes may not have optimal cytoplasmic conditions in vitro77. 
Furthermore, with alteration and maintenance of the epigenome, how do we ensure 
erasure by 10.5 dpc when the primordial germ cells reach the genital ridges and begin 
global de-methylation? What is the optimal duration to expose m2 to different enzymes 
and co-factors? It is said that primary DMRs established during gametogenesis, at least 
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partially, dictate secondary DMRs that are established post-fertilization8. By establishing 
the correct paternal epigenome pre-fertilization, is it assured that subsequent levels and 
areas of methylation will remain within physiologic development range? Embryonic 
development can only continue past mid-gestation with proper paternal de-methylation at 
certain loci; without it zygotic gene activation and pre-implantation development fails40. 
Zygotic genome activation removes faulty methylation to prevent hindrance to 
transcriptional programs.  
Regarding timely erasure, in vivo, the level of DNA methyltransferase activity 
naturally decreases throughout preimplantation development77, which may allow the 
natural cascade of developmental events. This also brings to mind localization 
mechanisms of enzymes. Between the 1-cell and 8-cell stages, DNMT1, a methylation 
maintenance enzyme found in both sperm and ova, is predominantly located in the 
cytoplasm77. During the 8-cell stage, the enzyme is preferentially located in the nucleus; 
but by the morula stage, the enzyme is again located predominantly in the cytoplasm77. 
Simply having the right amount of enzymes and cofactors may not be sufficient to cause 
proper imprinting in germ cells; imprint constriction is a delicately orchestrated process 
that may prove harder to recreate. 
Although it was stated above that establishing primary DMRs could enable 
automatic establishment of secondary DMRs, this may not occur so easily in m2 with a 
paternal imprint. The reason is because secondary DMRs include epigenetic 
modifications from post-fertilization histones newly incorporated from the recipient 
ovum (e.g. m1). Despite changing the epigenome of m2, the germ cell still lacks 
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protamines and the prerequisite hyperacetylation machinery and associated histones for 
the nucleosome remodeling that occurs during sperm maturation and triggers post-
fertilization histone-protamine exchange. 
 
Different Stages of Meiosis and Sexual Maturation between Germ Cells of Interest 
Another challenge in replacing the m2 maternal epigenome with a paternal 
epigenome would be the incongruence in imprint and stage of meiosis. Paternal imprints 
are quickly established perinatally, and play a critical role in the regulation of both 
meiosis and spermatogenesis. The paternal imprint dictating the step-wise transformation 
of primary spermatocyte to mature sperm may not be of use to m2.  Mature sperm has 
“programs” that provide resistance against mutagenesis, as it must undergo multiple 
mitoses before reaching ova for fertilization. To have an imprint in the absence of 
spermatogenic substrates can lead to dysregulation of another process in the m2 germ 
cell. For example, the presence of SUV39H1/2 in male germ cell has been associated 
with the post-fertilization formation of paternal pronuclei—will this still be a necessary 
factor in m2, or will the presence of this factor, in combination with other m2 factors, 
result in dysregulation and apoptosis? And while m2 may not endure the same physical 
journey as a mature sperm would in vivo, it may face physical and chemical challenges to 
its integrity in vitro. By not undergoing spermatogenesis in the testes, perhaps the m2 
germ cell may not be equipped properly. 
Also, while it was said it would be preferable to utilize a non-growing, secondary 
oocyte in metaphase II, oocytes are often harvested from ovarian hyperstimulation.  
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Hyperstimulation causes growth and maturation of the oocyte, meaning it will establish 
its maternal imprint by the time it ovulates. This is good because meiotic recombination 
will occur and there would be less of incongruence with having paternal imprints during 
meiosis II in the m2 germ cell. Specifically, by not having to maintain the paternal 
imprint through prophase I, paternal enzymes, SUV39H1/2 or G9A, responsible for 
catalyzing H3K9 methylation and maintaining heterochromatin formation for proper 
homologous chromosome recombination26 would also not have to be expressed and 
maintained or supplemented. It seems that mature oocytes attained from hyperstimulation 
could be de-methylated through enzymatic means, or like in Li et al. (2018), through 
multiple passaging of cells.  
 
The Issue of Protamines and Other Spermiogenetic Factors  
Several studies reported abnormal expression of protamines in spermatids of 
infertile men58 While imprints are not involved in protamine-histone exchange, 
protamines improve reproductive competence through enabling fertilization, and early 
embryo development. This may be because spermiogenesis (maturation of the sperm) 
occurs when there is global exchange of histone proteins to transition proteins to 
protamines. 
During the first exchange, histones are hyperacetylated. These are then recognized 
by a testis-specific bromodomain protein, BRDT, which is key in normal nuclear 
condensation and spermatid development. BRDT may need to be considered in m2 
production. Other histone-acting enzymes involved in spermiogenesis like H3K9me1/2 
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demethylase, JMJDA1, and histone demethylase M115 may also be necessary for m2 
imprint maintenance40. 
Furthermore, it is also not known if all the testes-specific histone variants 
incorporated during histone-protamine exchange during spermiogenesis (e.g. H2AL1/2, 
H2A.Bbd, H1t2, Hils1, and H2A.Lap1) contribute to paternal epigenetic inheritance. 
However, deletion of Hlt2 results in delayed chromatin condensation, defective 
spermatids, and reduced fertility40. Additionally, a human testis/sperm-specific histone 
H2B, hTSH2B, was recently identified in 20% of mature sperm, and is thought to be 
involved in post-fertilization sperm nucleus de-condensation 61—which could improve 
reproductive competence. 
Going back to the topic of protamines, a study by Cho et al. (2003) shows that 
protamine haploinsufficiency of either PRM1 or PRM2 results in alteration in the 
organization and integrity of sperm DNA used in ISCI procedure. The study posited that 
the reduced level of PRM2 and its positively charged arginine groups fail to neutralize 
the negatively-charged phosphate groups on DNA and result in reduced chromatin 
density.  Protamines are also involved crossing over and chromosome synapsis during 
meiosis, displaying their indispensability to reproductive success. The process of 
protamine exchange itself requires careful study to understand its regulation, as it 
seamlessly replaces paternal histones for protamines and then protamines for maternally-
derived histones. 
It should be considered whether the maternal histones placed into paternal 
pronuclei contain unique methylation patterns critical to normal embryological 
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development. The study by Hogg & Western (2015) illustrates the failure of round 
spermatid injections (ROSI) to produce comparable reproductive outcomes to injections 
using mature spermatozoa (ICSI)40. ROSI embryos provide a uniquely suited model for 
studies of paternal genome reprogramming because round spermatids have not undergone 
the same global chromatin remodeling and histone-protamine exchange that mature 
spermatozoa have.  
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Figure 14. Differences in ROSI and ICSI methylation levels 63 
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Embryos formed from spermatid microinsemination start to develop with aberrant 
genome-wide DNA methylation states in their paternal pronuclei (Figure 14). As 
mentioned earlier, the paternal genome in the zygote must be de-methylated accordingly 
post-fertilization for subsequent zygotic gene activation. In the Kishigami et al. (2006) 
experiment, methylation states diverged as early as four hours between round spermatids 
and mature sperm and resulted in disparate methylation profiles in zygotes. The 
methylated H3K9 state is observed in the spermatid-derived genome of ROSI and 
appears to persist through the one-cell stage just as the H3K9me3 in the maternal genome 
does. 
The presence of under-methylated H3K9 can be observed due to the fact that 
histones of the sperm-derived pronuclei are provided post-fertilization by the oocytes. 
The round spermatids, on the other hand, do not undergo histone-protamine exchange and 
thus carry their original paternal histones with their H3K9me3 marks. Thus, the ability to 
maintain undermethylation in the paternal pronuclei through the first embryonic mitosis 
is acquired during spermiogenesis. This leads to the observed differences in DNA 
methylation in the paternal zygotic genome, where round injected spermatids lacked the 
ability to prevent abnormal re-methylation that seems to occur mainly during S-phase.  It 
seems that the same mechanism of developmental incompetence occurs in somatic 
nuclear transfer, as nuclei from somatic cells carry their own histones and modifications 
that may not be compatible with the developmental stage. Thus, chromatin structure is a 
major regulator of imprint maintenance through crucial stages of development. 
Findings from Barton et al. (2001) in parthenogenetic, gynogenetic and triploid 
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digynic embryos show similar failures. Immunofluorescence staining with an antibody 
against 5-mc shows that the cellular machinery of the fertilized egg cannot demethylate 
the second maternal pronuclei in parthenogenetic, gynogenetic and triploid digynic 
embryos or re-methylate the additional (already de-methylated) paternal genome in 
androgenetic and triploid diandric embryos. This suggests that differential zygotic de-
methylation results from differences in the remodeling of paternal and maternal 
chromatin structures post-fertilization, i.e. sperm nuclear decondensation and protamine-
histone exchange. As expected, these methylation reprogramming resulted in high 
incidence of early pregnancy failure64. 
As a solution to the lack of histone-protamine exchange, trichostatin A (an 
inhibitor of histone deacetylases) could be implemented. TSA could provoke suppression 
of re-methylation in the spermatid-derived genome improve the success rate of ROSI63. 
While TSA-treated pre-implantation embryos exhibited developmental toxicity in the 
study by Ma et al. (2001), application of TSA in the correct amount to ROSI zygotes 
might improve their subsequent embryonic development since TSA treatment reduces 
zygotic DNA methylation specifically in the spermatid-derived genome. It leaves 
pericentromeric H3K9me3 heterochromatin untouched, preventing activation of satellite 
elements.  
 
Other Paternal Factors 
 
Aside from nucleosome remodeling complexes, paternal imprints require 
paternally-expressed factors such as piRNAs, DNMT3B, and tRFs for imprint 
maintenance. piRNAs and associated PIWI proteins are required for establishment of 
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methylation on Rasgrf1-DMR and on transposition loci 9. Apparently, germ cytoplasm 
can be inducted into nuage, a structure that contains Piwi proteins and is common to all 
animal germ cells 87. Existence of nuage allows for post-transcriptional regulation and 
gives rise to the chromatoid body found in late spermatocytes and round spermatids 29. 
Tudor domain-containing protein-1 (Tdrd1) is also found in nuage of spermatogonia and 
spermatocytes, and is essential for spermatogenesis 88. Tdrd1 binds to Piwi proteins and 
provides a necessary signal for MIWI2 localization; without it, TEs cannot be repressed, 
which may compromise fertility. Furthermore, Trdr9, which is involved in chromosome 
synapsing during meiosis, has its localization regulation interwoven with Tdrd1 and MILI 
expression89, pushing us towards caution when considering reproductive interventions. 
As mentioned before, epididymal tRFs have an important role during 
development of the pre-implantation embryo. By suppressing MT-LTRs and MuERV-L 
LTRs, the embryo can move beyond 2-cell pluripotency stage. Reproductive 
interventions would include their introduction into the m2 genome by mutation/ DNA 
insertion. Alternatively, DNMT1 and Hells could be upregulated in the m2 germ cell so 
that there is not overexpression of these MT-LTRs and MuERV-L LTRs. 
Maternal factors that are exclusively expressed in ova must also be considered. 
Remember that HP1-Beta and H3K9me3 protect maternal sites against CBX2 targeting, 
and that SUV39h, HP1-Beta, and DPPA3 maintain H3K9me3. These factors would have 
to be removed from the oocyte’s cytoplasm or repressed in expression so that 
asymmetrical epigenetic programming is suppressed in the m2 germ cell. Without 
heterochromatin lacking H3K9me3 and the absence of SUV39h , PRC1 cannot act73. 
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Additionally, it should be recognized both gametes contribute to the pluripotency 
of the developing zygote. During oocyte maturation, oocytes actually undergo a histone 
exchange, although not for protamines. Maturing oocytes incorporate oocyte-specific H1 
linker histone variant H1foo, macro H2A, and variant H3.3, the lattermost involved in 
pre-implantation reprogramming and re-activation of pluripotency programs. In fact, 
maternal H3.3 and its chaperone protein HIRA is required for male pronuclei formation80. 
Without maternal H3.3 and HIRA, mice cannot develop beyond the zygote stage40. 
Furthermore, the maternal germ cell also supplies PRC1 components that facilitate the 
H3K27me3 in the heterochromatin and euchromatin regions in the paternal line, slowly 
shifting the zygote into the proper (bivalent) epigenetic state for development90. 
Returning to discussion of histone variant incorporation in the maturing oocyte, there is 
also hyperacetylation of histones, which permits transcription in early oocyte growth. 
Without going into detail, maturation of female germ cell and embryo 
developmental competence is also enabled by chromatin condensation—as only those 
displaying a meiotic spindle (MS) can in fact be considered as true mature, 
developmentally competent Metaphase II (MII) stage oocytes91—facilitated by HDAC1 
and HDAC2.The similarities in the maturation process of gametes could be good for the 
creation of m2, however at the same time, it is ambiguous with what may happen with 
our interventions. If we were to get a non-growing oocyte and incorporate the histone 
variants of male germ cells and the testes-specific enzymes involved in histone-protamine 
exchange, would m2 respond similarly to hyperacetylation, or would hyperacetylation of 
	55 
the m2 genome (even with the paternal epigenome) induce growth and maturation of the 
m2 oocyte? 
One of the anticipated barriers in this scenario would be nuclear condensation for 
histone-protamine exchange. Mature sperm have completed meiosis II before 
spermatogenesis, whereas oocytes resume meiosis after fertilization. While the secondary 
oocyte completes meiosis II, sperm undergoes protamine-histone exchange in zygote. 
Perhaps the timing of nuclear condensing poses another logistical that could be 
overcome. Maturation promoting factor (MPF), expressed only in MII oocytes functions 
to induce condensation of chromosomes in the maturing oocyte. MPF could be used, but 
MPF is also known to induce decondensation of sperm nuclei92—in m2, how do we get 
both effects? The condensing for preparation of histone-protamine transition and then 
subsequent decondensation of its pronuclei?  
Cytoplasmic elements serve as vectors for epigenetic information, and are 
necessary for reproductive competence. While epigenetics can be altered to get proper 
expression of these cytoplasmic factors in germ cells, inducing multiple modifications to 
epigenomes and genomes would be uncontrolled and unwise. As illustrated in Figure 14 
below, unintended changes in methylome and phenotype increase in severity with 
increased number of assisted reproductive technology (ART) procedures. 	
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Figure 15. Risk of Placentomegaly and Hypomethylation Increases with Number of 
ART Procedures93	
	
 
Looking at the Li et al. (2018) experiment, it seems that many of the barriers and 
complications with the proposed methods described above could be simply bypassed by 
direct deletion of appropriate imprinted genes. Three imprinted region knock outs (H19, 
IG, and Rasgrf1) by CRISPR-Cas9 in phESC nuclei and seven imprinted region knock 
outs in androgenotic haploid embryonic stem cell nuclei fused with their respective same-
sex germ cell produced bi-maternal (14% live birth rate) and even bi-paternal pups (2.5% 
live birth rate), the former with placental and body weights comparable to in vivo pups38. 
Although this is a major success in reproductive technology, there is still the induction of 
major mutations that could disrupt the health of whole populations. 
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ETHICS: RISK ASSOCIATED WITH IN VITRO PROCEDURE ALONE 
Growth Restriction and Abnormal Placentation 
Despite the continual rise in children born to ART, ART is still thought to be 
associated with pregnancy complications such as low birth weight and abnormal 
placentation. Using ART procedures such as hormonal stimulation, egg retrieval, in vitro 
fertilization (IVF), intra-cytoplasmic sperm injection (ICSI), micro-manipulation of 
gametes, exposure to culture medium, pre-implantation genetic diagnosis, in vitro oocyte 
maturation is said to disrupt epigenetic programming via oxidative, thermal, and 
mechanical stress. This may be particularly concerning with IVF, which could introduce 
these stresses during a critical period of epigenetic reprogramming. In mice, culture of 
embryos in commonly used media such as Whitten's medium results in developmental 
rates that are retarded when compared to those of embryos that develop in vivo,77 these 
IVF embryos showing reduced levels of expression of many genes.  
Across mice studies, ART is associated with disproportionate growth of the 
placenta. Some findings demonstrate that even a minimal in	vitro manipulation such as 
non-surgical embryo transfer can impact placental development93. It is hypothesized that 
the placenta is undergoing stress and compensatory mechanisms94, which can lead to an 
observed lower fetal birth weight. Looking into metabolic changes in IVF mouse 
concepti in a study by Bloise et al. (2012), amino acid transport was reduced by 58% in 
IVF-placenta, with associated amino acid transport reductions in the fetus, compared to 
spontaneous concepti. This observation, combined with analyses of proliferation and 
apoptosis (there being more proliferation rather than a decrease in apoptosis), suggests 
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placental hypertrophy. Although these metabolic changes did not affect general birth 
weight between concepti in this particular study, it could influence metabolism and 
development later in life. There were different growth patterns between IVF and 
spontaneous concepti: IVF embryos were reduced in size at E12.5, but by birth, reached 
the same size as the controls. Regarding placental development, there were fewer TE 
cells around the time of implantation in IVF blastocysts, by mid-gestation the placenta 
were of normal size, but by the end of gestation the IVF placenta exceeded the weight of 
the controls. 
Figure 16. Placental and Fetal Weight-Growth Patterns95 
 
Most studies in humans report at least one type of morphological difference in 
ART placentas: increased placental weight, placental: fetal ratio, placental thickness, 
abnormal umbilical cord insertion and abnormal placental shape94. Actin cytoskeleton 
dysregulation secondary to DNA-methylation-DNA-expression changes could affect 
allantois or chorion formation, and chorioallantoic fusion, which, coupled with induced 
	59 
hematopoiesis and vasculogenesis changes could lead to abnormal junctional zone and 
labyrinth formation and impaired nutritional transport in IVF placentas96. In mice 
concepti, levels of mRNA for Glut3 were found to be decreased during pre-implantation 
development and continue to be lower in IVF placentae thorough late gestation95. Glut3 
expression is said to be epigenetically regulated97, and its decreased expression may be 
attributed to alterations in pre-implantation embryo conditions with IVF procedures93. 
This is backed by Sui et al. (2014) and Tan et al. (2016) where a global reduction in DNA 
methylation was detected in IVF extraembryonic tissues at E7.5 using methylated DNA 
immunoprecipitation (MeDIP)98 and altered expression of many genes affecting genetic 
information processing, cytoskeleton, energy and amino acid metabolism, and 
vasculogenesis/angiogenesis were found in IVF extra-embryonic tissue and placenta at 
E7.5 and E10.5 96. 
 
Imprinting Disorders 
IVF procedures can result in ICR hypo-methylation and bi-allelic expression of 
many disease-relevant imprinted genes. In an experiment by Doherty et al. (2000), DNA 
methyltransferase activity in mouse embryos cultured in Whitten's medium was shown to 
be decreased when compared to embryos cultured in KSOM+AA, a medium that more 
closely approximates the in vivo nutritional environment. This coincided with biallelic 
expression of H19 and undermethylation of one of its upstream imprinting control 
domains. While not all imprinted genes were affected by in Whitten’s medium (in vitro 
conditions), some key developmental genes are affected77 
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Similar to mice, a recent trial on human ISCI placenta exhibited hypomethylation 
of the H19/IGF2 ICR and a corresponding increase in H19 expression99. This finding, 
however, is limited due to sample size (n=35) and inability to control for confounding 
factors such as error in ICSI technique or male subfertility. However, another recent 
study by Choux et al. (2018) reported lower DNA methylation at H19/IGF2	
and KCNQ1OT1 DMRs and the two transposon families LINE-1Hs and ERVFRD-1 in the 
placenta of babies conceived by ART. In another study, ICSI children showed a 
significantly decreased DNA methylation age at birth, lagging approximately half a week 
behind the controls100. 
The serious implications of wielding epigenetic alterations during critical periods 
of development, whether due to ART itself or improper execution of technique, include 
imprinting disorders such as fetal growth restriction syndrome Silver-Russell syndrome 
(SRS), which is characterized by the loss of DNA methylation at the ICR controlling the 
IGF2-H19 locus 58. Beckwith-Wiedemann syndrome (BWS), the overgrowth syndrome, 
is caused in up to 90% of patients by an alteration in growth regulatory genes located on 
chromosome 11p15.5. This region includes DMRs for IGF2-H19 (IG-DMR) and 
KCNQ1OT1 (TSS-DMR), where 60-70% of BWS patients have epigenetic defects. 
BWS has an estimated worldwide frequency of 1 in 13,700 naturally conceived 
babies and a weighted relative risk of 5.2 in children conceived by ART101. BWS is a 
complex and heterogeneous syndrome that presents with prenatal macrosomia, which is 
defined as postnatal overgrowth over the 97th percentile or two standard deviations above 
the mean. Other common features include polyhydramnios, omphalocele, macroglossia, 
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hypotonia, abdominal wall defects, and increased susceptibility to developing tumors102.  
In a study by Tenorio et al. (2016), 88% percent of BWS patients born 
specifically via ART had hypomethylation of KCNQ1OT1: TSS-DMR in comparison 
with 49% for patients with BWS conceived naturally. Interestingly, none of the patients 
with BWS born via ART had hypermethylation of H19/IGF2: IG-DMR, neither CDKN1 
C mutations nor paternal uniparental disomy 11 (all also associated with forms of BWS). 
Patients with BWS born via ART also had an increased frequency of advanced bone age, 
congenital heart disease, and decreased frequency of earlobe anomalies, compared to 
those with BWS from spontaneous fertilization102. 
Majority of reports published suggest that ART is associated with the imprinting 
disorders mentioned above103,104. A recent comprehensive meta-analysis attempted to 
reveal association between multiple imprinting disorders and conception by ART105. It 
included data from 23 studies that related conception following ART to occurrence of 
imprinting disorders, and yielded the following associations with a history of ART: AS, 
summary odds ratio (sOR) = 4.7 (95% confidence interval (CI) 2.6-8.5, 4 studies); BWS, 
sOR = 5.8 (95% CI 3.1-11.1, 8 studies); Prader-Willi (PWS), sOR = 2.2 (95% CI 1.6-3.0, 
6 studies); Silver-Russell (SRS) syndrome, sOR = 11.3 (95% CI 4.5-28.5, 3 studies); with 
only one study reporting associations with transient neonatal diabetes mellitus (TNDB) 
and sporadic retinoblasoma (RB)105. A systematic review and meta-analysis done by 
Lazaraviciute et al. (2014) on imprinting disorder prevalence in children conceived by 
IVF or ICSI compared to spontaneous birth showed a  combined odds ratio of 3.67 (95% 
CI 1.39, 9.74) of having any imprinting disorder in children conceived through IVF/ 
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ISCI. However, it should be emphasized again that the lack of adequate correction for 
crucial confounding factors (e.g. heterogeneity in the types of fertility treatment, the 
imprinted regions studied, the tissues used and the methods of measurement) and small 
sample sizes of studies remain to be major limitations. 
An obvious confounding factor to ART-induced congenital abnormalities would 
be infertility factors inherent to the parent (e.g. reduced semen quality, propensity for 
DNA damage)106,107. Since most couples undergoing ART have fertility defects, it is 
difficult to say whether the ART procedures or the epigenetics inherited from the parents 
are responsible for epigenetic changes 100. Thus, there is a strong selection bias present in 
studies inquiring ART induction of epigenetic changes. Other confounding factors 
elucidated in a prospective study by Gentilini et al. (2018) include several environmental 
and behavioral conditions that are able to affect epigenetic variability in developing fetus: 
cord blood cell composition, pre- or post-conception supplementation of folates, birth 
percentiles, gestational age, cesarean section, pre-gestational mother's weight, parents' 
BMI and obesity status, presence of adverse pregnancy outcomes, mother's smoking 
status, and season of birth108. This study better separated confounding factors from the 
effects of ART using a multivariate approach. 
After multiple testing correction in the Gentilini et al. (2018) study, no 
statistically significant difference emerged in the number of cord blood stochastic 
epigenetic variations (SEVs) or in the methylation levels between in vitro- and in vivo-
conceived babies. The inability to identify differences between cases and controls 
suggests that the number of stochastic epigenetic variations potentially induced by ART 
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was not greater than that naturally produced in response to maternal behavior or other 
common environmental factors. However, this study was largely limited by its small 
sample size, its use of data from a single lab in a single IVF center, its whole-genome 
analysis only covering about 2% of total CpG sites, and the use of cord blood, which is 
not epigenetically representative of all tissues and cells in the newborn. Still, despite 
these limitations, the study provides insight on confounding factors that must be 
considered when assessing risks of ART on epigenetic aberrations. 
Continuing discussion, findings by El Hajj et al. (2017) challenge the often-
dichotomous framework of whether ART causes epigenetic-linked diseases or not. This 
study compared DNA methylation between non-ICSI and ICSI offspring. Although 
several of thousands of CpG sites throughout the genome displayed significant between-
group methylation differences, both ICSI and spontaneously conceived children varied 
within the normal range of methylation variation—noting that there was also an extensive 
overlap in methylation levels between ART and control samples. The ICSI cohort 
consisted of healthy newborns without reported imprinting disorders, intrauterine growth 
retardation, congenital malformations, delivery and postnatal complications. El Hajj et al. 
(2017) suggests that the presence of disease risk in ART children may be the product of a 
multifactorial model, where the accumulation of many subtle and specific epigenetic 
changes may eventually modulate the phenotype into a disease state109. This model goes 
beyond the simple “on/off” understanding of methylation at gene promoters and accounts 
for a multi-tiered epigenetic regulation with regulatory elements that mediate interactions 
between genes and the ART environment. In other words, the children conceived by ART 
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procedures in this study may have epigenetic changes, but they may not have “struck” 
any changes in the regulatory system of disease-implicated genes; or they may have 
various epigenetic changes in disease-implicated genes and in their regulatory system but 
not enough “strikes” to hit the threshold for a particular disease, perhaps not having the 
right combination of “strikes” to manifest disease symptoms. Although these children 
born to ART did not present with disease, the significant between-group methylation 
differences are still concerning, as they can increase transgenerational risk of disease. 
There is evidence that the maternal environment can contribute to epigenetic effects that 
span more than two generations even if only a single generation was exposed to the 
inducing factor109, which has widespread implications in the health of the human race. 
 
Epigenetically-Induced Cancer Susceptibility 
Gene-specific hypermethylation is a characteristic of most types of cancer, 
usually occurring within the promoter regions of tumor suppressor genes (TSGs)110,111. 
An example of this is methylation and silencing of IGF2R, a tumor suppressor in liver 
and breast cancer 112. In parallel, global hypomethylation is a general hallmark of cancer, 
and is associated with the aberrant activation of proto-oncogenes as well as chromosome 
instability110.  For example, loss of imprinting (LOI) has been implicated in 
neuroblastoma and invasive breast cancer development111. 
Myelodysplastic syndrome (MDS) predisposes one to acute myelogenous 
leukemia (AML), and a notable proportion of mutations affecting these genes involve 
epigenetic maintenance. In particular, DNMT dysregulation often occurs 113, suggesting a 
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role of epigenomic dysregulation in the pathogenesis of MDS. Various genes, including 
cell cycle regulators, apoptotic genes, and DNA repair genes, are usually epigenetically 
silenced but can have roles in pathogenesis and transformation to leukemia. Khan et al. 
(2013) reveals distinct methylation patterns between high- and low-risk subsets of this 
disease. Complex epigenetic dysregulation of this disease results in a cancer resistant 
to DNMT inhibitors azacitdine and decitabine.  
Abnormal HDAC activity can also lead to aberrant expression of genes regulating 
cell proliferation, cell cycle, and apoptosis and transcriptional repression of tumor 
suppressor genes. HDACs are also said to regulate the acetylation of various non-histone 
proteins important for cell growth and differentiation (e.g. TSG expression)114. Cutaneous 
T-cell lymphoma is a condition of HDAC dysregulation. It results in HDAC inhibition, 
which prevents HDACs from removing acetyl groups and allows DNA to remain 
transcriptionally active, leading to a pleiotropic set of downstream effects, including 
activation of cell death, cellular differentiation, and inhibition of angiogenesis114. 
The price of autonomy for AFAB couples is too high. The level of uncertainty 
with m2 interventions is too great to attempt. To introduce epialleles into the human 
species without a comprehensive understanding of epigenetic networks of regulation 
would be irresponsible. No child should be subjected to increased risk of stunted 
development, imprinting disorders, or cancer.  	  
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DISCUSSION 
Kaguya and Mice Models 
 
 The Kono et al. (2004) experiment suggests that altering the inheritance of the 
gynogenetic embryo imprint extends development. Not only did the umbilical cord 
develop to normal thickness in the ngH19 Δ3 /fgwt (compared to ngwt /fgwt)— as one would 
expect with paternal imprinted gene contributions—but gene expression profiles were 
more similar between ngH19 Δ3 /fgwt and controls than ngwt /fgwt and controls. Only two 
out of 34 imprinted genes, Grb10 and Nnat, respectively, were up and downregulated in 
the modified gynogenote (ngH19 Δ3 /fgwt) by a factor of two. Comparatively, 11 non-
imprinted genes were downregulated and Grb10 was upregulated in the ngwt /fgwt. The 
difference in gene expression between the two gynogenotes was 28-fold (average of 842 
affected genes) — indicating the risk of altered gene regulation when the paternal imprint 
is not present. 
Since Igf2/ H19 and Dlk1 imprinted gene domains are conserved between mouse 
and human paternal genomes, downregulating the expression of Igf2 to prevent a second 
dose of maternal imprinting on second maternal genome (m2) seems like simple addition. 
However, the studies cited in this review have proven that epigenetics is not additive; 
epigenetic regulation often has unquantifiable effects. Sometimes these effects are 
positive. In the Kono study (2004), survivor gynogenotes were able to decrease Gtl2 and 
activate Dlk1 expression without direct manipulation and avoid perinatal death and 
stunted growth that occurs with distal chromosome 12 maternal disomies in mice (where 
Dlk1 and Gtl2 are located) 85. While it can be easy to focus on the positive findings of 
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these studies (more recently Li et. al, 2018) in the pursuit of expanding access to 
reproductive technologies, caution must be taken with these findings. 
It should also be acknowledged that the majority of the studies included in this 
literature review utilized the mouse model to gain insight on epigenetic regulatory 
models. While genomic organization of maternal and paternal ICRs (location and CpG 
composition) between murine and human species are said to be conserved3, paternal 
methylation imprints are established only at two of the three paternal mice ICRs. Human 
paternal imprinted genes include the H19-IGF2 ICR on chromosome 11 and the DLK1-
DIO3 ICR on chromosome 14. 
Though ICRs do not function when transgenically introduced from human to 
mouse, ICRs appear to operate according to a similar mechanism of action12. For 
example, in the H19/Igf2 domain there are four CTCF-binding sites in the mouse rather 
than the seven found in humans. The sixth CTCF-binding site is what retains the paternal 
imprint in the H19/Igf2 domain though. Loss of methylation at this site results in Wilm’s 
tumors, bladder cancer, colon cancer, and osteosarcoma12.  
Regarding proteins, there is slighter retention of histones during the genome-wide 
histone-protamine exchange. In humans, 5–10% of histones are retained in mature 
spermatozoa, and are thought to harbor paternal imprints26, in mice there is only 1% 
retention40. And although PIWIL3, the fourth PIWI protein to be identified in humans has 
been discovered, an association between piRNAs and human PIWI proteins has not yet 
been identified 9. 
The timeline of human events also differ from mice: human PGCs are specified 
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during week 2 of development, migrate to the genital ridge around week 5, and specify 
their sex between weeks 6-8 40. Weeks 2-9 of human development are analogous to E6.5-
E.13.5 in mouse germ cells, when the first round of global demethylation occurs116. 
Compared to mice (14%, 7%), there is more complete demethylation, with 7.8% and 
6.0% median methylation levels in male and female PGCs, respectively116. This occurs 
through passive and active demethylation: DNA methylation levels drop alongside 
expression of DNMT3A, DNMT3B, and recruitment factor UHRF1 by week 7, and 
TET1- and BER enzymes are upregulated116. Similar sites of L1, ERVK, and Alu 
elements show resistance to de-methylation, for protection. Re-methylation seems to 
occur at week 19 in the human paternal ICR. 
 
Rights for AMAB couples? 
To argue for the autonomy of AFAB couples means that we must argue for 
AMAB couples to be granted the same right. Androgenesis is only known to occur in 
three organisms: several species in the freshwater clam genus Corbicula, Saharan cypress 
trees (Cupressus dupreziana), and stick insects in the genus Bacillus, which is much 
fewer than naturally-occurring parthenogenotes117. This may be due to the lack of 
mitochondrial DNA and cytoplasm inheritance in androgenotes and the lack of necessary, 
complex ecological conditions and mutations to induce and maintain androgenesis in a 
population (e.g. high selection pressure against these androgenotes/ high extinction rate 
even when there is reproductive competency). 
Indispensible products provided by maternal germ cells include MPF; maternal 
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H3.3 and its chaperone protein HIRA required for male pronuclei formation and 
development beyond the zygote stage; and PRC1 components, RNF2 and its paralogue 
RING1; are critically expressed during oocyte growth in the MII oocyte, making it 
equally as hard to produce a paternal equivalent of m2. PRC1 components are responsible 
for the regulation of 2500 transcripts in the zygote. Because both paternal genomes are 
transcriptionally silent, it has been determined across different species, including 
mammals, that early development of the zygote depends on maternal factors (e.g. stored 
maternal mRNA transcripts)118. To prove this, microinjection of Rnf2 mRNA into the 
early zygote does not rescue embryonic development, and leads to death before the 2-cell 
stage. Furthermore, PRC1 components are crucial modulators of chromatin, as they 
provide differential methylation along paternal and maternal lines in the early zygote. 
CD9, essential for the fusion of gametes, is also provided by oocyte microvillar 
membrane, and maintains the oocyte’s normal shape 92. It should also be noted that 
TET3, which primes paternally-imprinted loci for de-methylation in the paternal 
pronuclei and improves developmental outcomes past mid-gestation is expressed largely 
in oocytes. 
Regarding humans, there is also a disparity in the number of ICRs inherited 
through each parental line—the maternal genome has greater than fifteen ICRs and 
paternal genome has two—thus, the ability to compensate for the loss of ICRs are more 
likely to be inadequate. Separate considerations would have to be taken with the 
production of viable human androgenotes. For example, PRMT5/ Blimp1 pathway is a 
critical regulator in maintaining TEs methylated exclusively in the maternal line and 
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would need to be compensated for 34. MuERV-L LTRs will need to be upregulated and 
other maternal line TE promoters will need to be tended to.  
While it seems that we can fix the levels of methylation with supplementing, as 
we have gathered from studies, compensative dosing does not seem to completely work. 
In the study by Takahashi, Kobayashi, & Kono (2010), restoration of Dlk and Rtl1 
expression was not sufficient to rescue all  IG-DMR (-/+) mouse neonates. Correct gene 
dosing (production of double mutant IG-DMR (-/+) / Gtl2 (+/-)) did prolong life to 
perinatal stages, but it seems that parent-specific effects such as inheritance of un-
methylated IG-DMR from the maternal ICR specifically inhibits androgenesis. The Lin et 
al. (2003) study also showed IG-DMR KO/+ lethality with 2-fold increase in Dlk1 and 
Dio3 expression and 4.5 fold increase in Rtl1 expression. However, the Li et al. (2018) 
experiment showed that, with many deletions and tetraploid complementation, bi-paternal 
mice can be produced, though the margin of survivability is low (coinciding with lower 
body and placental weights). 
Figure 17. The Production of Live Bi-paternal Mice using Knock Outs and 
Tetraploid Complementation38
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Another argument that could precipitate would be that individuals should be 
allowed to be sole contributors to their children’s genome. As discussed by McKone & 
Halpern (2003), the evolutionary consequences of shifting a sexually-reproducing 
population to an asexual one (e.g. pseudogamy, fusion of haploids, or haploid doubling) 
may lower long-term survival, as genetic variation would be greatly limited. Closely 
related would be the phenomenon of first cousins mating and causing a bottleneck effect 
in the local population. While autonomy should be granted to all individuals, the risk of 
transgenerational, off-target effects is too great. 
 
CONCLUSION 
In order to truly consider human gynogenesis, molecular, ethical, and financial 
barriers would have to be overcome. The complexity of epigenetic networks elucidates 
how difficult mammalian offspring production is. Events in gamete production, 
fertilization, and embryonic development all occur on a stringent spatiotemporal timeline, 
with close regulation of contributing factors. The maternal and paternal imprint network 
work in synergy, as they give subtle signals to each other, allowing for the development 
of an organism. 
While it is desired to promote the rights of AFAB couples in the realm of 
reproductive technologies, the field of epigenetics is not understood well enough to 
promote any successful intervention. To recreate the differential methylation of the 
paternal germ cell would have to be done step-wise, and may be challenging to emulate 
in vitro. In practice, there are still many large gaps that need to be filled before 
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production of an m2 germ cell can be attained. While theories can be entertained, it 
would be premature to follow through with suggestions outlined. The damage of 
attempting to create m2 in the human population currently would be multi-fold, as 
genomes and epigenomes could be passed through multiple generations of families. To 
avoid the risks of deleterious medical conditions in offspring as well as introducing 
dangerous epialleles into the population, adoption is encouraged as a robust alternative to 
bi-maternal ART.	
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APPENDIX 
 
Androgenesis- Production of an embryo from two paternal pronuclei. 
Differentially-Methylated Region (DMR)- An imprinting control element that regulates 
expression of an entire set of imprinted genes within an imprinting cluster. Derived from 
retrotransposons and other exogenous CpG-rich sequences and integrated within   
genome 7. 
Gynogenesis- Must be distinguished from parthenogenesis; receives its genetic 
contributions from two mothers rather than one. Often relies on the re-activation of 
meiosis II, release from “cytostatic factor arrest,” by sperm fertilization although no 
paternal DNA content is transmitted. The activating factor in sperm is a specific isoform 
of phospholipase C ζ (PLC ζ) that is introduced into oocyte during fusion of gametes, and 
is re-sequestered into pronuclei upon exiting metaphase II. Gynogenetic lineages may 
also depend on donor sperm for their centrioles, for the formation of centrosomes and 
proper mitosis in proliferating cells of the developing embryo1. The articles referenced 
use the terms parthenogenotes and gynogenotes interchangeably, but note that this thesis 
abides by the definitions provided here. 
Imprinting Control Region- A type of DMR. ICRs are several kilobases in size and 
most of them correspond to CpG islands that are transcriptionally active on the 
unmethylated allele 13. 
Parthenogenesis- It is a natural form of asexual reproduction in which an embryo 
develops from an unfertilized egg; its pronuclei derived only from one mother. 
Parthenogenetic animals generate oocytes with the complete number of chromosomes by 
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duplicating their chromosomes before meiosis (“endomitosis” or “endoreplication,”) or 
by fusion of two oogonia (see Figure 18)1. This is commonly observed in reptile and 
insect species, and can occur facultatively in sexually reproducing species when males 
are absent. Parthenogenesis can be induced experimentally by chemical suppression of 
second polar body extrusion during chemical activation (cytochalasin B). 
Parthenogenesis differs from gynogenesis in that pronuclear transfer is performed. In 
gynogensis, this occurs after sperm or chemical activation of the egg. 
 
Figure 18. Parthenogenetic maintenance of diploidy1 
 
Note: Parthenogenetic activation and sperm fertilization of the egg both cause the egg to 
expose binding sites for Concanavalin A to synthesize DNA and to divide. Cortical 
granules, however, are not released with parthenogenetic activation 88. 
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PRM2- A single protamine gene is expressed in most mammals, but a unique, second 
protamine is expressed in mice and humans. The protein encoded by the second gene 
(Prm2) constitutes about half of the protamine in human sperm and two thirds of the 
protamine in mouse sperm 120.  
Pseudogamy- Any reproductive process that requires pollination but does not involve 
male inheritance.  
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